Insights

Clinical stage Focus Target opportunities in partnering or licensing discussions with biotechnology firms and CROs looking to enhance their portfolio with antigen-specific immune tolerance induction platforms, aligning with Tolerion's clinical-stage status and novel technology.

Platform Advantage Highlight potential collaborations around the antigen-specific immune tolerance induction platform to attract biotech players seeking targeted immune modulation capabilities for autoimmune, transplant, or chimeric antigen receptor therapy adjacencies.

Financial Scale Position partnerships with mid-market firms given revenue under one million and a lean team; explore co-development or milestone-based deals that align with capital-efficient research programs.

Strategic Alliances Leverage parallels with peers of similar size and stage to approach alliances with larger biopharma players seeking external innovation in immune tolerance, potentially unlocking licensing or joint development frameworks.

Digital Footprint Utilize the company’s techn stack and digital presence to tailor outreach, offering value-adds such as research collaboration, data-sharing opportunities, and virtual partnering options to accelerate early-stage discussions.

Tolerion, Inc. Tech Stack

Tolerion, Inc. uses 8 technology products and services including WordPress, MySQL, Twemoji, and more. Explore Tolerion, Inc.'s tech stack below.

WordPress

Content Management System

MySQL

Database

Twemoji

Font Scripts

jQuery

Javascript Libraries

Underscore.js

Javascript Libraries

Lua

Programming Languages

PHP

Programming Languages

Bootstrap

UI Frameworks

Tolerion, Inc. Email Formats	Example	Percentage
FLast@tolerion.bio	JDoe@tolerion.bio	60%
Last@tolerion.bio	Doe@tolerion.bio	40%

Tolerion, Inc. Email Formats

Example

Percentage

FLast@tolerion.bio

JDoe@tolerion.bio

60%

Last@tolerion.bio

Doe@tolerion.bio

40%

Frequently Asked Questions

What is Tolerion, Inc.'s phone number?

You can contact Tolerion, Inc.'s main corporate office by phone at

+1-650-575-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Tolerion, Inc.'s official website and social media links?

Tolerion, Inc.'s official website is tolerion.bio and has social profiles on LinkedIn.

How much revenue does Tolerion, Inc. generate?

As of September 2026, Tolerion, Inc.'s annual revenue is estimated to be <$1M.

What is Tolerion, Inc.'s SIC code and NAICS code?

Tolerion, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Tolerion, Inc. have currently?

As of September 2026, Tolerion, Inc. has approximately 11 employees across 1 continents, including North America. Explore Tolerion, Inc.'s employee directory with LeadIQ.

What industry does Tolerion, Inc. belong to?

Tolerion, Inc. operates in the Biotechnology Research industry.

What technology does Tolerion, Inc. use?

Tolerion, Inc.'s tech stack includes WordPress, MySQL, Twemoji, jQuery, Underscore.js, Lua, PHP and Bootstrap.

What is Tolerion, Inc.'s email format?

Tolerion, Inc.'s email format typically follows the pattern of FLast@tolerion.bio. Find more Tolerion, Inc. email formats with LeadIQ.

Tolerion, Inc.

Q: What is Tolerion, Inc.'s official website and social media links?

Tolerion, Inc.'s official website is tolerion.bio. Tolerion, Inc. has social profiles on LinkedIn.

Q: How many employees does Tolerion, Inc. have currently?

Tolerion, Inc. has approximately 11 employees.

Q: What industry does Tolerion, Inc. belong to?

Tolerion, Inc. operates in the Biotechnology Research industry.

Q: What technology does Tolerion, Inc. use?

Tolerion, Inc.'s tech stack includes Lua, Google Fonts API, Twemoji, OpenResty, MySQL.

Q: What is Tolerion, Inc.'s NAICS code?

Tolerion, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchCalifornia, United States11-50 Employees

Tolerion, Inc. is a clinical-stage biotechnology company focused on immune modulation through an antigen-specific tolerance induction platform. Its portfolio seeks to selectively induce tolerance to particular antigens, with the goal of reducing harmful immune responses while preserving overall immune function. By pursuing targeted immune tolerance, the company aims to address immune-mediated conditions through a treatment approach that avoids broad immunosuppression. Based in South San Francisco, California, the company operates with a small to mid-sized team within the biotechnology research sector. Its customers and partners are researchers and biopharmaceutical developers seeking antigen-specific approaches to immune-related diseases, where a targeted tolerance strategy could complement or enable new therapies.

Insights

Similar companies to Tolerion, Inc.

Selecta Biosciences

Anokion

sanofi

ImmuNext

Moderna

Novo Nordisk

Provention Bio, a Sanofi Company